Decision of Adjuvant Systemic Treatment in HR+ HER2- Early Invasive Breast Cancer: Which Biomarkers Could Help?

Decision of Adjuvant Systemic Treatment in HR+ HER2- Early Invasive Breast Cancer: Which Biomarkers Could Help?

Marie Alexandre,1 Aurélie Maran-Gonzalez,2 Marie Viala,1 Nelly Firmin,1 Véronique D’Hondt,1,3,4 Marian Gutowski,5 Céline Bourgier,3,6 William Jacot,1,3,4 Séverine Guiu1,3,4 1Department of Medical Oncology, Institut Régional du Cancer d...

Full description

Bibliographic Details
Main Authors: Alexandre M, Maran-Gonzalez A, Viala M, Firmin N, D'Hondt V, Gutowski M, Bourgier C, Jacot W, Guiu S
Format: Article
Language:English
Published: Dove Medical Press 2019-12-01
Series:Cancer Management and Research
Subjects:
breast cancer
adjuvant chemotherapy
biomarkers
Online Access:https://www.dovepress.com/decision-of-adjuvant-systemic-treatment-in-hr-her2--early-invasive-bre-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/decision-of-adjuvant-systemic-treatment-in-hr-her2--early-invasive-bre-peer-reviewed-article-CMAR

Similar Items